Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07JMG
|
|||
Drug Name |
Boronic acid derivative 4
|
|||
Synonyms |
PMID26413912-Compound-61
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
INFINITY PHARMACEUTICALS, INC. CASTRO, Alfredo, C. GROGAN, Michael, J. SNYDER, Daniel, A
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H16BNO3
|
|||
Canonical SMILES |
B(C1=CC2=C(C=C1)C(=O)N(C=C2)CCC3=CC=CC=C3)(O)O
|
|||
InChI |
1S/C17H16BNO3/c20-17-16-7-6-15(18(21)22)12-14(16)9-11-19(17)10-8-13-4-2-1-3-5-13/h1-7,9,11-12,21-22H,8,10H2
|
|||
InChIKey |
MPFOFZNQFUHKAK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.